0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Actions of Levodopa and Dopamine in the Central Nervous System

Theodore L. Sourkes, PhD
JAMA. 1971;218(13):1909-1911. doi:10.1001/jama.1971.03190260025006.
Text Size: A A A
Published online

In 1958, Carlsson1 suggested that dopamine (3-hydroxytyramine; 3,4-dihydroxyphenethylamine) is intimately involved in the control of motor functions. This view has since been amply supported by neurochemical, pharmacological, and neurological evidence. The role of dopamine was deduced in the first place from its high concentrations in the basal ganglia of the brain and certain associated structures. This pointed to some independent physiological activity of the amine in the brain. Dopamine has weak pharmacodynamic actions in biological assay systems devised originally to study the actions of norepinephrine and epinephrine, and this fact seemed to exclude it from any important role peripherally, except as a biochemical intermediate. In 1961, initial clinical trials of the acute effects of levodopa in patients with Parkinson's disease in Montreal2 and Vienna3 revealed the potent neuropharmacological actions of this amino acid, fully demonstrated in 1967 by Cotzias and his colleagues. Developments in the biological and

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();